Predictive value of hypoxia in advanced head and neck cancer after treatment with hyperfractionated radio-chemotherapy and hypoxia modification
- PMID: 27527617
- DOI: 10.1007/s12094-016-1541-x
Predictive value of hypoxia in advanced head and neck cancer after treatment with hyperfractionated radio-chemotherapy and hypoxia modification
Abstract
Purpose: Hypoxia has predictive value in head and neck cancer (HNC). It has been well described, albeit in a small number of clinical Centres. The aim of this study was to describe our experience using the polarographic probe technique to assess the predictive value of tumour oxygenation in patients with advanced HNC treated with hyperfractionated radio-chemotherapy. Hypoxia modification was induced using percutaneous spinal cord stimulation (SCS).
Methods/patients: Male patients (n = 12; stage IVb n = 8; IVa n = 4; mean age 58: range 46-70 years) with advanced HNC were evaluated. Planned therapy was hyperfractionated-radiotherapy, oral tegafur (precursor of 5-fluorouracil) and hypoxia modification using SCS. Pre-treatment analyses included: haemoglobin levels and tumour oxygenation (using the Eppendorf polarographic probe device). Oxygenation was expressed as median-pO2 (in mmHg) and hypoxia as the percentage of pO2 values ≤5 mmHg (HP5) and ≤2.5 mmHg (HP2.5).
Results: Lower haemoglobin levels were directly correlated with median pO2 (p = 0.017) and inversely correlated with HP5 (p = 0.020) and more advanced stages (IVb vs. IVa; p = 0.028). Patients who subsequently developed systemic metastasis had tumours that were more hypoxic, with lower median pO2 (p = 0.036) and higher HP5 (p = 0.036). The subgroup of patients with HP2.5 above the median (the most hypoxic tumours) had lower loco-regional control (p = 0.027), cause-specific survival (p = 0.008), and overall survival (p = 0.008).
Conclusions: Higher tumour hypoxia showed predictive value in HNC in our study, and was significantly associated with lower overall survival, cause-specific survival, and loco-regional control. Tumour hypoxia determination could be used to select patients who would most benefit by hypoxia modification during chemo-radiotherapy of HNC.
Keywords: Anaemia; Head and neck cancer; Polarographic probes; Predictive and prognostic value; Spinal cord stimulation; Tumour hypoxia modification.
Similar articles
-
Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer.Acta Oncol. 2004;43(4):396-403. doi: 10.1080/02841860410026189. Acta Oncol. 2004. PMID: 15303502
-
Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study.Radiother Oncol. 2005 Oct;77(1):18-24. doi: 10.1016/j.radonc.2005.06.038. Epub 2005 Aug 10. Radiother Oncol. 2005. PMID: 16098619 Clinical Trial.
-
Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial.Lancet Oncol. 2015 Feb;16(2):221-32. doi: 10.1016/S1470-2045(14)71200-8. Epub 2015 Jan 15. Lancet Oncol. 2015. PMID: 25596659 Clinical Trial.
-
Concomitant chemoradiotherapy versus altered fractionation radiotherapy in the radiotherapeutic management of locoregionally advanced head and neck squamous cell carcinoma: An adjusted indirect comparison meta-analysis.Head Neck. 2015 May;37(5):670-6. doi: 10.1002/hed.23661. Epub 2014 Apr 30. Head Neck. 2015. PMID: 24596112 Review.
-
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.Lancet. 2006 Sep 2;368(9538):843-54. doi: 10.1016/S0140-6736(06)69121-6. Lancet. 2006. PMID: 16950362 Review.
Cited by
-
Nitrate increases cisplatin chemosensitivity of oral squamous cell carcinoma via REDD1/AKT signaling pathway.Sci China Life Sci. 2021 Nov;64(11):1814-1828. doi: 10.1007/s11427-020-1978-4. Epub 2021 Sep 17. Sci China Life Sci. 2021. PMID: 34542810
-
REDD1 overexpression in oral squamous cell carcinoma may predict poor prognosis and correlates with high microvessel density.Oncol Lett. 2020 Jan;19(1):431-441. doi: 10.3892/ol.2019.11070. Epub 2019 Nov 8. Oncol Lett. 2020. PMID: 31897156 Free PMC article.
-
Combined inhibition of JAK1,2/Stat3‑PD‑L1 signaling pathway suppresses the immune escape of castration‑resistant prostate cancer to NK cells in hypoxia.Mol Med Rep. 2018 Jun;17(6):8111-8120. doi: 10.3892/mmr.2018.8905. Epub 2018 Apr 20. Mol Med Rep. 2018. PMID: 29693186 Free PMC article.
-
Predicting hypoxia status using a combination of contrast-enhanced computed tomography and [18F]-Fluorodeoxyglucose positron emission tomography radiomics features.Radiother Oncol. 2018 Apr;127(1):36-42. doi: 10.1016/j.radonc.2017.11.025. Epub 2017 Dec 19. Radiother Oncol. 2018. PMID: 29273260 Free PMC article.
-
Ozone Therapy as Adjuvant for Cancer Treatment: Is Further Research Warranted?Evid Based Complement Alternat Med. 2018 Sep 9;2018:7931849. doi: 10.1155/2018/7931849. eCollection 2018. Evid Based Complement Alternat Med. 2018. PMID: 30271455 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical